Suchergebnisse - "Kümmerle, Tim"

PubPharm (32)

1

Dynamics and durability of HIV-1 neutralization are determined by viral replication

enthalten in: Nature medicine | 2023

von Schommers, P. | Kim, D. | Schlotz, M. | +47

2

No increase in transient viremia (blips) when switching to a NRTI-free 2 drug regimen (2DR) of DTG+bDRV : a sub-analysis of the DUALIS study

enthalten in: HIV medicine | 2023

von Monin, M. | Kümmerle, T. | Schneider, J. | +15

3

Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir : a DUALIS sub-study

enthalten in: AIDS care | 2022

von Olliges, E. | Bührlen, B. | Fischer, F. | +14

4

Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP) : a randomised, open-label, phase 2A trial

enthalten in: The Lancet. Microbe | 2022

von Gruell, H. | Gunst, J. | Cohen, Y. | +22

5

Switching to a NRTI-free 2 drug regimen (2DR) : a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

enthalten in: HIV research & clinical practice | 2022

von Monin, M. | Kümmerle, T. | Schneider, J. | +15

6

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

enthalten in: HIV research & clinical practice | 2021

von Monin, M. | Kümmerle, T. | Schneider, J. | +16

7

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

enthalten in: AIDS research and therapy | 2021

von Wolf, E. | Boesecke, C. | Balogh, A. | +9

8

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

enthalten in: AIDS research and therapy | 2021

von Wolf, E. | Boesecke, C. | Balogh, A. | +8

9

Metabolic and renal changes when switching to NRTI-free dolutegravir-containing 2 drug regimens : a sub-analysis of the DUALIS study

enthalten in: Infection | 2021

von Monin, M. | Kümmerle, T. | Schneider, J. | +13

10

Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1 : A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study

enthalten in: Open forum infectious diseases | 2020

von Spinner, C. | Kümmerle, T. | Schneider, J. | +48